Press Releases

DUBLIN, Oct. 7, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in eye care, today announced the launch of three new over-the-counter (OTC)  REFRESH® RELIEVA™ products: REFRESH® RELIEVA™, REFRESH® RELIEVA™ PF (preserv

HERDECKE, Germany, Oct. 7, 2019 /PRNewswire/ -- EP Map System, GmbH, a Herdecke, Germany-based company that has developed a suite of technologies focused on electrophysiology (EP) procedures, today announced the closing of a $25 million Series A financing round led by Ajax Health. EP Map's product line includ

--- Health Canada's approval of additional licensed space at Mississauga, Ontario facility provides significant scale in production and processing.--- Additional licensed cultivation capacity earmarked to further serve the EU and other international markets.--- Newly licensed processing operat

DUBLIN, Oct. 7, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the  presentation of new health economics and outcomes research at the 32nd Annual Psy

WALTHAM, Mass., Oct. 7, 2019 /PRNewswire/ -- Sojournix, a clinical stage biopharmaceutical company dedicated to developing and commercializing transformative new medicines for the treatment of women's health and neuroendocrine disorders, announces that Daniel Grau, President and Chief Executive Officer of Sojournix, will present at the LSX

PALO ALTO, California, Oct. 7, 2019 /PRNewswire/ -- Next Insurance, the leading digital Insurtech company transforming small business insurance, today announced that it has raised $250 million in a Series C funding round from Munich Re. The funds will enable new pro

NEW YORK, Oct. 7, 2019 /PRNewswire/ -- The Aesthetic Society, a 2,600 member organization comprised of board certified plastic surgeons devoted to aesthetic plastic surgery, announced

LAS VEGAS, Oct. 7, 2019 /PRNewswire/ -- For the first time, SilverSummit Healthplan will offer a Medicare Advantage HMO plan. Allwell from SilverSummit Healthplan, will be available to those eligible for Medicare and living in Clark, or Nye County effective January 1, 202

INDIANAPOLIS, Oct. 7, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that results from the global Phase 3 RELAY trial of CYRAMZA® (ramucirumab) in previously untreated patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) were published in

WASHINGTON, Oct. 7, 2019 /PRNewswire/ -- LUNGevity Foundation, the nation's premier lung cancer-focused nonprofit organization, is pleased to announce the expansion of its partnership with Savor Health to bring Ina® – Your Personal Intelligent Nutrition Assistant – to those affected by lung cancer. Ina® is a knowledge-based personalized nutrition